- support
- info@evidentic.com
- +49 (0) 30 959 99 8831
A monoclonal antibody-Fc engineered is a mAb designed to induce cytotoxicity against B-cell malignancies by antibody effector functions mediated via their fragment crystallizable (Fc) region. Fc region, which naturally exists in mAbs, can have unique properties and thereby be potentially used for different applications. Due to these unique properties, various Fc-engineering antibodies have been developed lately in order to enhance the anti-tumor potential of mAbs.
Showing the single result
ProductBatch | Antigen | Molecular Class | Drug Brand | Product Concentration | CoA | Quantity per vial | Storage Temperature | Expiry Date | Price from | |
---|---|---|---|---|---|---|---|---|---|---|
PD-L1 |
Monoclonal Antibody-Fc engineered |
Tecentriq® |
60 mg/mL |
yes |
12 mg |
-80°C |
2022.03 |
359,00 € |
Evidentic GmbH
Am Mühlenberg 10
14476 Potsdam | Germany